Baseline predictors of clinical and imaging progression in Parkinson’s disease: Results from the PPMI study
Objective: To identify clinical, imaging, and biochemical measures, obtained early in the disease course that predict clinical and dopamine transporter (DAT) imaging progression in PD.…Evolution of Motor and Non-Motor Manifestations in Prodromal Parkinsonism
Objective: To trace the evolution of early motor and non-motor manifestations of synculeinopathy from the stage of idiopathic REM sleep behavior disorder (iRBD) until defined…Motor and Non-motor Features Predict Freezing of Gait in Parkinson’s Disease
Objective: To investigate and evaluate behavioral predictors of conversion to Freezing of Gait in Parkinson’s Disease (PD). Background: Freezing of Gait (FOG) has devastating consequences…Sniffing Parkinson’s in the masses: Volatilome analysis for Parkinson’s Disease diagnostics
Objective: To identify volatile compounds in the skin which can be used to provide an early diagnosis in Parkinson's disease (PD). Background: There is a…Botulinum toxin A (BoNT A) treatment of postsurgical/posttraumatic focal movements not responding to oral therapy
Objective: We report three cases of focal movement disorder following trauma or surgery. Oral therapies were ineffective in both patients and symptoms dramatically improved after…REM sleep-related episodes in children with Narcolepsy type 1 after treatment with Sodium Oxybate
Objective: We aimed to analyze the effect of Sodium Oxybate (SO) on motor events occurring during nighttime in children affected with Narcolepsy type 1 (NT1).…Accessing Speech and Language Therapy (SLT) in a Multi-Disciplinary Movement Disorders Clinic (MDC)
Objective: To enable access to SLT for patients with Parkinson’s (PwP) in the MDC at the Royal Berkshire Hospital (RBH). Background: A successful bid in…Predicting Alpha-Synuclein Pathology by REM Sleep Behavior Disorder Diagnosis
Objective: Determine sensitivity, specificity and predictive value of clinician diagnosed probable REM sleep behavior disorder (PRBD) in predicting alpha-synuclein pathology. Background: Inability to accurately diagnose…Changes in brain network activation (BNA) in patients with fragile x-associated tremor/ataxia syndrome (FXTAS)
Objective: We aimed to assess the ability of Brain Network Activation (BNA) EEG analysis to differentiate between patients with fragile X-associated tremor/ataxia syndrome (FXTAS), Parkinson’s…Auto-antibodies and clinical-imaging associations in patients with Movements Disorders from a Neurological Institute in Mexico
Objective: Determine the prevalence of systemic and anti-neuronal antibodies in Movement Disorders patients from a third-level neurological hospital. Background: Autoimmunity is a common cause of…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.